Diagnostic Accuracy of Fine-Needle Biopsy in the Detection of Thyroid Malignancy

Authors:

Abstract
Fine-needle biopsy (FNB) has been an integral part of thyroid nodule diagnosis and workup since the late 1970s.1 Thyroid nodules with concerning features on ultrasonography are referred for FNB, and resultant cytopathology and possible adjuncts (eg, genetic testing) guide the shared decision-making process with the patient.2,3 Recent developments for evaluating thyroid nodules include improved resolution of ultrasonography for nodule detection,4 development of Thyroid Imaging Reporting and Data System (TIRADS),5,6 and widespread use of ultrasonography guidance in FNB technique.7 In addition, clinical practice has evolved due to the adoption of The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) and other reporting criteria,8 and evolutions in technique (eg, liquid-based preparation and rapid on-site cytopathologic evaluation).9,10

This publication has 66 references indexed in Scilit: